Steven Cohen's position in Cytokinetics is currently worth $2.02M. That's 0.00% of their equity portfolio (1200th largest holding). The first Cytokinetics trade was made in Q2 2019. Since then Steven Cohen bought shares 24 more times and sold shares on 21 occasions. The stake costed the investor $1.32M, netting the investor a gain of 53% so far.